AtaiBeckley enters merger agreement with Eli Lilly and Albali
AtaiBeckley Inc. has executed a merger agreement with Eli Lilly and Company and Albali Acquisition Corporation. The transaction is expected to combine clinical development capabilities with Lilly's extensive resources to advance targeted therapies.
View filing at SEC.gov →